Dual-targeting triplebody 33-16-123 (SPM-2) mediates effective redirected lysis of primary blasts from patients with a broad range of AML subtypes in combination with natural killer cells
| Image |  |
|---|---|
| Description | scholarly article by Todd A Braciak et al published 2018 in OncoImmunology |
| Author/s |
author: Annemarie Honegger |
| Publication date | 2018 |
| Language | English |
| Country of origin | |
| Wikipedia link | |
| Copyright status | |
| Missing/wrong data? | Edit Wikidata item |